Related Experiment Video
Updated: Feb 3, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Ejection Fraction Pros and Cons: JACC State-of-the-Art Review
1Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Insights
Ejection fraction (EF) remains a cornerstone in cardiology for assessing cardiac function. This review evaluates if EF
Area of Science:
- Cardiology and Cardiovascular Diseases
- Cardiac Imaging and Diagnostics
Background:
- Ejection fraction (EF) is a fundamental metric in cardiology, crucial for diagnosing and managing various heart conditions like heart failure and myocardial infarction.
- The traditional development of EF assessment predates current patient demographics and the rising prevalence of heart failure with preserved ejection fraction (HFpEF).
Purpose of the Study:
- To critically evaluate the continued relevance and justification of using ejection fraction (EF) in modern cardiology.
- To assess the performance of EF against newer biomarkers for left ventricular (LV) function, especially in contemporary clinical scenarios.
Main Methods:
- This is a review article, synthesizing existing literature and clinical guidelines on ejection fraction.
- The review analyzes the historical context, current applications, and limitations of EF in light of evolving cardiovascular medicine.
Main Results:
- EF is a well-established tool but faces challenges in detecting subclinical LV dysfunction and subtle changes in sequential testing.
- The demands on EF have increased, particularly for monitoring patients on cardiotoxic therapies and those with HFpEF.
Conclusions:
- The review questions whether the extensive evidence supporting EF adequately addresses the sophisticated diagnostic needs of modern cardiology.
- It highlights the need to consider newer markers of LV function alongside EF to meet current clinical expectations.
Abstract:
Ejection fraction (EF) reflects both cardiac function and remodeling, and is widely recognized as a valuable diagnostic and prognostic tool. Its use in a variety of settings, ranging from heart failure and myocardial infarction to valvular heart disease, has made it a cornerstone of modern cardiology, pervading guidelines and practice. However, the development of the test was in another era, with younger patients and a lower prevalence of heart failure with preserved EF. The performance expectations of EF in the current era are also demanding-in relation to detection of subclinical LV dysfunction, and especially relating to recognition of changes in LV function on sequential testing-for example in patients taking cardiotoxic drugs. This review discusses whether the impressive evidence base for EF justifies its ongoing use in the context of newer markers of LV function, and the sophisticated questions posed by modern cardiology.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Subcellular Fractionation
Differential Centrifugation
Differential centrifugation is...
Partial Fractions
Mixtures of Gases: Dalton's Law of Partial Pressures and Mole Fractions
Group Design

